Privium Fund Management B.V. - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$159,022
-56.0%
64,907
-46.8%
0.03%
-71.9%
Q1 2023$361,369
-41.9%
122,084
-61.7%
0.12%
-48.7%
Q4 2022$621,972
-12.4%
318,960
+16.6%
0.24%
-8.5%
Q3 2022$710,000
+40.0%
273,654
+40.5%
0.26%
+53.6%
Q2 2022$507,000194,8170.17%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Privium Fund Management B.V. 318,960$621,9720.24%
Murchinson Ltd. 522,203$1,075,6860.14%
K.J. Harrison & Partners Inc 208,376$581,3820.11%
Redmond Asset Management, LLC 75,000$144,0000.05%
ARMISTICE CAPITAL, LLC 375,000$772,4630.01%
ZEKE CAPITAL ADVISORS, LLC 45,000$92,6960.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BANK OF AMERICA CORP /DE/ 472$9720.00%
UBS Group AG 1,441$2,9680.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders